Dove Medical Press Patients and methods: In this prospective, open-label, single-group study, 106 previously untreated patients with a baseline systolic blood pressure (SBP) of 150–200 mmHg, and a diastolic blood pressure (DBP) of 110 to 120 mmHg, started with ...
Medical News Today Candesartan has a significantly lower risk of death at one to five years than losartan when given to patients with heart failure, Swedish researcher...
Science World Report In a collaborative effort, researchers from St. Olavs Hospital in Trondheim, Norway and the Norwegian University of Science and Technology (NTNU) have found that the drug Candesartan is as effective in combating migraines as the commonly prescribed ... and more »
Drug Discovery & Development Takeda Pharmaceutical Co. Ltd. received notice of sanctions imposed by the Japan Pharmaceutical Manufacturers Association (JPMA) for promotional activities regarding Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J). The sanctions ...
Medscape BOSTON — The angiotensin receptor blocker candesartan (Atacand, AstraZeneca Pharmaceuticals LP) is safe and as effective as the beta blocker propranolol in preventing migraine headaches, according to a new study. The results of the randomized, ...
Medycyna Praktyczna The ARB Trialists Collaboration: Effects of telmisartan, irbesartan, valsartan, candesartan and losartan on cancers in 15 trials enrolling 138 769 individuals. J. Hypertens, 2011; 29: 623–635 43. Pasternak B., Svanström H., Callréus T. i wsp.: Use of ...
GP online Causative medication can be continued in mild cases, but should be stopped or changed in painful or worsening gynaecomastia. Suitable alternative cardiovascular medications include candesartan , bisoprolol and metoprolol. Surgical excision can be ...
Pharmacy News ... of accelerated price disclosure cuts will see a range of medicine prices slashed, including Atorvastatin (down by 25%); Rosuvastatin (16%), Clopidogrel (28.9%), Topiramate (19%), Olanzapaine (29%), Fentanyl (20%), Famciclovir (22%) and Candesartan ... and more »
